Vanda Pharmaceuticals Inc - Company Profile
Powered by 
All the data and insights you need on Vanda Pharmaceuticals Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Vanda Pharmaceuticals Inc Strategy Report
- Understand Vanda Pharmaceuticals Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Vanda Pharmaceuticals Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| US20240139160A1 | Application | Pharmaceutical combination comprising a selective s1p1 receptor agonist | A61K31/4015; A61K31/225; A61K31/22; A61K31/426; A61K9/0053; A61K31/27 | May 02, 2024 |
| US20240139161A1 | Application | Pharmaceutical combination comprising ponesimod | A61K31/426; A61K31/421; A61P25/28; A61K31/167 | May 02, 2024 |
| CN117915909A | Application | 自闭症谱系障碍患者睡眠紊乱的治疗 | April 19, 2024 | |
| CN117897161A | Application | 反义寡核苷酸(ASO)基因抑制和治疗 | April 16, 2024 | |
| ES2965488T3 | Grant | Uso de tasimelteón para el tratamiento de trastornos afectivos en pacientes mayoritariamente negroafricanos | A61K31/343; A61K45/06; A61K9/0053; A61P25/24 | April 15, 2024 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer